A carregar...
AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors
BACKGROUND. AZD1480 is a novel agent that inhibits Janus-associated kinases 1 and 2 (JAK1 and JAK2). The primary objective of this phase I study was to investigate the safety and tolerability of AZD1480 when administered as monotherapy to patients with solid tumors. METHODS. Thirty-eight patients wi...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3720635/ https://ncbi.nlm.nih.gov/pubmed/23847256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0198 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|